420 related articles for article (PubMed ID: 3865743)
21. [A and B apoproteins and serum lipids in clinically healthy males].
De Giorgio LA; Seghieri G; Gironi A; Dami D; Mammini P; Bartolomei G
Quad Sclavo Diagn; 1982 Mar; 18(1):1-9. PubMed ID: 7156327
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
Herrmann W; Hanf S; Schütz C; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
Z Gesamte Inn Med; 1988 Feb; 43(4):86-92. PubMed ID: 3376506
[TBL] [Abstract][Full Text] [Related]
23. [Comparative characteristics of the basic blood lipid and apolipoprotein spectrum in groups of patients from Moscow and Bordeaux with ischemic heart disease].
Perova NV; Bonne Zh; Nechaev AS; Shcherbakova IA; Metel'skaia VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):66-72. PubMed ID: 3707722
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of lipids and apolipoproteins in angiographically assessed coronary artery disease in Japanese patients.
Sawada Y; Kotake H; Hoshio A; Ogino K; Nawada T; Hisatome I; Fujimoto Y; Mashiba H
J Med; 1992; 23(6):433-42. PubMed ID: 1293253
[TBL] [Abstract][Full Text] [Related]
25. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
26. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
Masuda D; Sugimoto T; Tsujii K; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Kawamoto T; Matsuyama A; Sakai N; Komuro I; Yamashita S
Eur J Clin Invest; 2012 Sep; 42(9):992-9. PubMed ID: 22587365
[TBL] [Abstract][Full Text] [Related]
27. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
[TBL] [Abstract][Full Text] [Related]
28. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
29. Coronary sclerosis risk factors in males with special reference to lipoproteins and apoproteins: establishing an index.
Kawanishi M; Nakamoto A; Konemori G; Horiuchi I; Kajiyama G
Hiroshima J Med Sci; 1990 Sep; 39(3):61-4. PubMed ID: 2283305
[TBL] [Abstract][Full Text] [Related]
30. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
Ford ES; Cooper RS; Simmons B; Castaner A
J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
[TBL] [Abstract][Full Text] [Related]
31. [C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males].
Olszewski R; Grabysa R; Warmiński J; Makowski T; Szczechowicz R; Piechota W; Adamus J
Pol Merkur Lekarski; 2002 Jul; 13(73):14-7. PubMed ID: 12362497
[TBL] [Abstract][Full Text] [Related]
32. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.
Noma A; Yokosuka T; Kitamura K
Atherosclerosis; 1983 Oct; 49(1):1-7. PubMed ID: 6651909
[TBL] [Abstract][Full Text] [Related]
33. [The importance of plasma lipids and apolipoproteins in the assessment of risk of myocardial infarction in the most common types of primary hyperlipoproteinemias].
Zeman M; Zák A; Vítková D; Dusek F
Cas Lek Cesk; 1991 Nov; 130(20-21):601-5. PubMed ID: 1769056
[TBL] [Abstract][Full Text] [Related]
34. Lipid markers, coronary score and coronary artery disease of stable angina pectoris type.
Kusá O; Luknárová O; Riecanský I; Zelenay J
Cor Vasa; 1987; 29(3):192-8. PubMed ID: 3621949
[TBL] [Abstract][Full Text] [Related]
35. Metabolic risk factors in the normolipidemic male patients with angiographically defined coronary artery disease.
Fujiwara R; Kutsumi Y; Hayashi T; Kim SS; Misawa T; Tada H; Nishio H; Toyota K; Tamai T; Nakai T
Jpn Circ J; 1990 May; 54(5):493-500. PubMed ID: 2232113
[TBL] [Abstract][Full Text] [Related]
36. Apolipoproteins as risk indicators of ischemic heart disease.
Winkler L; Schlag B; Ostermann G; Dargel R
Przegl Lek; 1989; 46(7):595-8. PubMed ID: 2587787
[TBL] [Abstract][Full Text] [Related]
37. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
[TBL] [Abstract][Full Text] [Related]
38. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
[TBL] [Abstract][Full Text] [Related]
39. [Lipoproteins as coronary risk or non-risk indicators in elderly people].
Herrmann W; Hanf S; Lindhofer HG
Z Gerontol; 1990; 23(6):338-44. PubMed ID: 2291302
[TBL] [Abstract][Full Text] [Related]
40. Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus.
Song J; Park H; Hong SH; Lee HK; Park YB; Kim JQ
Clin Chem Lab Med; 2000 May; 38(5):427-32. PubMed ID: 10952226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
